I kliniske forsøg med botulinum type A- neurotoksinkompleks rapporteredes det, at dysfagi forekommer mindre hyppigt med totaldoser under 200 E pr. behandlingsforløb.
In clinical trials with Botulinum toxin type A complex it was reported that dysphagia occurs less frequently with total doses below 200 U per treatment session.